The anticalmodulin drugs trifluoperazine and R24571 remove the activation of the purified erythrocyte Ca2+-ATPase by acidic phospholipids and by controlled proteolysis.
D002135:Calcium-Binding Proteins / Q000037:antagonists & inhibitors*; D000252:Calcium-Transporting ATPases / Q000097:blood*; D002147:Calmodulin / Q000037:antagonists & inhibitors*; D004789:Enzyme Activation; D004910:Erythrocyte Membrane / Q000201:enzymology*; D004912:Erythrocytes / Q000201:enzymology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D007700:Kinetics; D010713:Phosphatidylcholines; D010743:Phospholipids / Q000494:pharmacology*; D014268:Trifluoperazine / Q000494:pharmacology*
D002135:Calcium-Binding Proteins; D002147:Calmodulin; D007093:Imidazoles; D010713:Phosphatidylcholines; D010743:Phospholipids; D014268:Trifluoperazine; C031938:calmidazolium; C024990:asolectin; D000252:Calcium-Transporting ATPases